Seminars in Oncology
Volume 29, Issue 3 , Pages 280-285, June 2002

Challenges in developing a molecular characterization of cancer☆

Departments of Pathology and Genetics, Stanford University School of Medicine, Stanford, CA.

Abstract 

DNA microarrays are widely used to measure gene expression across thousands of genes in parallel. Recently, considerable efforts have been made to utilize this technology to improve our understanding of cancer and to identify novel diagnostic markers and therapeutic targets. Here, we detail some of the challenges in developing a molecular characterization of cancer and in translating these new discoveries towards clinical utility. Semin Oncol 29:280-285. Copyright 2002, Elsevier Science (USA). All rights reserved.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ Address reprint requests to Jonathan R. Pollack, MD, PhD, Department of Pathology, Stanford University School of Medicine, CCSR Building, Room 3245A, 269 Campus Dr, Stanford, CA 94305-5176.

PII: S0093-7754(02)50184-6

doi:10.1053/sonc.2002.32903

Seminars in Oncology
Volume 29, Issue 3 , Pages 280-285, June 2002

Article Tools

* Image Usage & Resolution